Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)
NCT04812496
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Covid19
SARS-CoV Infection
Tenofovir
Sponsor
Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud